Literature DB >> 1453478

Cloning of a novel TGF-beta related cytokine, the vgr, from rat brain: cloning of and comparison to homologous human cytokines.

U Sauermann1, R Meyermann, H J Schluesener.   

Abstract

Here we describe cloning of a TGF-beta related cytokine from a rat brain cDNA library. This novel cytokine, the vgr (vegetal related), is homologous to the vegetal (Vg1) gene of Xenopus (DL Weeks and DA Melton, Cell, 51:861-867, 1987). In rat brain mRNA a single 3.5 kb RNA could be detected by Northern blot analysis. Thus, this new cytokine is constitutively expressed in the central nervous system. A monoclonal antibody reactive with a synthetic peptide of vgr revealed a faint vgr-like immunoreactivity throughout the CNS, with more pronounced staining of hippocampal neurons, ependymal cells, cells of the choroid plexus, and hypophysis. Using the rat cDNA, two homologous human cytokine cDNAs encoding the human vgr and op-1 were cloned.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1453478     DOI: 10.1002/jnr.490330118

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  3 in total

1.  Comparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectors.

Authors:  Hongwei Li; Jin Zhong Li; Debra D Pittman; Andy Amalfitano; Gerald R Hankins; Gregory A Helm
Journal:  Int J Med Sci       Date:  2006-06-01       Impact factor: 3.738

2.  Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.

Authors:  Yinghua He; Ying Cui; Baiying Xu; Jun Gu; Wei Wang; Xiaoying Luo
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

3.  N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometry.

Authors:  Xianyu Li; Jing Jiang; Xinyuan Zhao; Jifeng Wang; Huanhuan Han; Yan Zhao; Bo Peng; Rugang Zhong; Wantao Ying; Xiaohong Qian
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.